https://www.biopharmawatch.com/news/PCVX/vaxcyte-invests-us-manufacturing-vaccine-production BiopharmaWatch en 2026-08-01T16:55:54.000Z cw-check-https://test.com/ https://www.biopharmawatch.com/news/PCVX/aktuelle-trends-verbesserte-soundsysteme-win-beatz BiopharmaWatch en 2026-08-01T10:13:53.000Z Aktuelle_Trends_und_verbesserte_Soundsysteme_rund_um_win_beatz_für_Audioliebhab https://www.biopharmawatch.com/news/PCVX/destinasi-impianmu-terwujud-aviamaster1-solusi-perjalanan BiopharmaWatch en 2026-08-01T10:12:34.000Z Destinasi_impianmu_terwujud_dengan_https_aviamaster1_com_solusi_perjalanan_terba https://www.biopharmawatch.com/news/PCVX/pak-aviator-risk-reward-gameplay-strategies BiopharmaWatch en 2026-08-01T09:23:43.000Z Potential_gains_soar_with_pak_aviator_balancing_risk_and_reward_in_every_flight https://www.biopharmawatch.com/news/PCVX/affidabile-confronto-scommesse-online-nuove-strategie BiopharmaWatch en 2026-08-01T09:07:52.000Z Affidabile_confronto_per_scommesse_online_con_the-kinbet-it_it_e_nuove_strategie https://www.biopharmawatch.com/news/PCVX/genuine-excitement-awaits-chickenroad-arcade-fun BiopharmaWatch en 2026-08-01T08:48:52.000Z Genuine_excitement_awaits_with_chickenroad_for_endless_arcade_fun_and_challengin https://www.biopharmawatch.com/news/PCVX/thefunbet-insights-and-winning-approaches BiopharmaWatch en 2026-08-01T06:21:59.000Z Analysis_reveals_insights_from_https_thefunbet_co_uk_and_potential_winning_appro https://www.biopharmawatch.com/news/PCVX/adorable-adventure-chicken-road-gaming BiopharmaWatch en 2026-08-01T06:20:04.000Z Adorable_adventure_awaits_with_thechickenroad-canada_ca_and_countless_daring_das https://www.biopharmawatch.com/news/PCVX/aktuelle-trends-crown-plays1-ch-spielmechaniken BiopharmaWatch en 2026-08-01T06:15:55.000Z Aktuelle_Trends_bei_crown-plays1_ch_sowie_spannende_Spielmechaniken_entdecken https://www.biopharmawatch.com/news/CORT/hypercortisolism-resistant-hypertension-cardiovascular-disease BiopharmaWatch en 2026-08-01T01:00:13.000Z Prevalence of Hypercortisolism in Individuals With Resistant Hypertension and Cardiovascular Disease https://www.biopharmawatch.com/news/FBLG/fibrobiologics-reports-q2-2026-results-clinical-trial-progress BiopharmaWatch en 2026-07-31T21:34:00.000Z FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate https://www.biopharmawatch.com/news/PFSA/profusa-signs-option-agreement-acquire-g3-vision-labs BiopharmaWatch en 2026-07-31T21:15:00.000Z Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs https://www.biopharmawatch.com/news/XRTX/xortx-announces-director-resignation BiopharmaWatch en 2026-07-31T21:00:00.000Z XORTX Announces Director Resignation https://www.biopharmawatch.com/news/ENTX/entera-bio-participate-canaccord-growth-conference BiopharmaWatch en 2026-07-31T20:30:00.000Z Entera Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference https://www.biopharmawatch.com/news/PRPO/precipio-q2-2026-shareholder-update-call BiopharmaWatch en 2026-07-31T20:00:00.000Z Precipio Announces Q2-2026 Shareholder Update Call https://www.biopharmawatch.com/news/PCVX/aviator-game-download-risk-management BiopharmaWatch en 2026-07-31T19:37:50.000Z Potential_rewards_await_with_aviator_game_download_and_careful_risk_management_t https://www.biopharmawatch.com/news/PCVX/covid-19-coronavirus-disease-2019 BiopharmaWatch en 2026-07-31T19:25:47.000Z Coronavirus disease 2019 https://www.biopharmawatch.com/news/IMRX/aja-harbert-joins-immuneering BiopharmaWatch en 2026-07-31T16:21:41.000Z Aja Harbert https://www.biopharmawatch.com/news/PCVX/stoiximan-new-platform-launch BiopharmaWatch en 2026-07-31T15:42:40.000Z Εύκολη_πρόσβαση_στη_στοιχηματική_πλατφόρμα https://www.biopharmawatch.com/news/IMRX/paris-offor-joins-immuneering BiopharmaWatch en 2026-07-31T15:36:28.000Z Paris Offor https://www.biopharmawatch.com/news/PCVX/considerable-progress-in-competitive-gaming BiopharmaWatch en 2026-07-31T14:52:07.000Z Considerable_progress_from_initial_steps_to_advanced_play_with_https_vegasheros- https://www.biopharmawatch.com/news/PCVX/automaty-z-magnesami-niespodzianki-i-wygrane BiopharmaWatch en 2026-07-31T14:50:57.000Z Automaty_z_magnesami_czyli_niespodzianki_i_wygrane_na_https_the-magnetic-slots_n https://www.biopharmawatch.com/news/PCVX/atmosphaere-kreieren-zuhause-neu-denken-thegolisimo BiopharmaWatch en 2026-07-31T14:47:35.000Z Atmosphäre_kreieren_und_das_Zuhause_neu_denken_mit_thegolisimo_at_für_individu https://www.biopharmawatch.com/news/MBRX/moleculin-announces-pricing-public-offering BiopharmaWatch en 2026-07-31T14:12:00.000Z Moleculin Announces Pricing of $9.3 Million Public Offering https://www.biopharmawatch.com/news/NCEL/newcelx-announces-1-4-million-financing-premium-pricing BiopharmaWatch en 2026-07-31T13:00:00.000Z NewcelX Announces Pricing of $1.4 Million Equity Financing at 20% Premium Pricing https://www.biopharmawatch.com/news/SDEV/stablecoin-development-corporation-q2-2026-results BiopharmaWatch en 2026-07-31T12:30:00.000Z Stablecoin Development Corporation Reports Second Quarter 2026 Financial Results https://www.biopharmawatch.com/news/NMAD/nomad-options-trading-begins-cboe BiopharmaWatch en 2026-07-31T12:30:00.000Z NOMAD Power Solutions Announces Options Trading Begins on Cboe Options Exchange https://www.biopharmawatch.com/news/OGN/organon-announces-quarterly-dividend BiopharmaWatch en 2026-07-31T12:30:00.000Z Organon Announces Quarterly Dividend https://www.biopharmawatch.com/news/PAVM/pavmed-business-update-conference-call-august-2026 BiopharmaWatch en 2026-07-31T12:30:00.000Z PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026 https://www.biopharmawatch.com/news/RDGT/ridgetech-fiscal-year-2026-financial-results BiopharmaWatch en 2026-07-31T12:30:00.000Z Ridgetech, Inc. Reports Fiscal Year 2026 Financial Results https://www.biopharmawatch.com/news/SPRC/scisparc-neurothera-quantum-platform-clinical-data-analytics BiopharmaWatch en 2026-07-31T12:20:00.000Z SciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics https://www.biopharmawatch.com/news/IRMD/iradimed-corporation-q2-2026-financial-results BiopharmaWatch en 2026-07-31T12:15:00.000Z IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results https://www.biopharmawatch.com/news/MBRX/moleculin-miracle-trial-positive-data-venetoclax-failure BiopharmaWatch en 2026-07-31T12:10:18.000Z Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients https://www.biopharmawatch.com/news/GCTK/lokahi-therapeutics-ai2-futures-lab-expansion BiopharmaWatch en 2026-07-31T12:00:00.000Z Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline https://www.biopharmawatch.com/news/ELUT/elutia-second-quarter-2026-financial-results BiopharmaWatch en 2026-07-31T12:00:00.000Z Elutia to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026 https://www.biopharmawatch.com/news/PMI/picard-medical-emperor-total-artificial-heart-architecture BiopharmaWatch en 2026-07-31T12:00:00.000Z Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026 https://www.biopharmawatch.com/news/ABBV/abbvie-reports-q2-2026-financial-results BiopharmaWatch en 2026-07-31T11:47:00.000Z AbbVie Reports Second-Quarter 2026 Financial Results https://www.biopharmawatch.com/news/ELAN/elanco-2025-impact-report-animal-health-innovation BiopharmaWatch en 2026-07-31T11:32:00.000Z Elanco Releases 2025 Impact Report, Demonstrating How Animal Health Helps Meet Society's Growing Needs https://www.biopharmawatch.com/news/MDCX/medicus-pharma-uae-authorization-teverelix-endometriosis-study BiopharmaWatch en 2026-07-31T11:30:00.000Z Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis https://www.biopharmawatch.com/news/NVO/novo-nordisk-zeus-phase-3-trial-update BiopharmaWatch en 2026-07-31T11:21:00.000Z Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation https://www.biopharmawatch.com/news/INMB/inmune-bio-q2-2026-financial-results-update BiopharmaWatch en 2026-07-31T11:15:58.805Z INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th https://www.biopharmawatch.com/news/OCGN/ocugen-participate-august-investor-conferences BiopharmaWatch en 2026-07-31T11:15:21.037Z Ocugen to Participate in Upcoming August Investor Conferences https://www.biopharmawatch.com/news/HOWL/werewolf-therapeutics-q2-2026-financial-results BiopharmaWatch en 2026-07-31T11:13:15.202Z Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates https://www.biopharmawatch.com/news/TENX/tenax-therapeutics-q2-2026-financial-results-update BiopharmaWatch en 2026-07-31T11:12:24.597Z Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update https://www.biopharmawatch.com/news/DTIL/precision-biosciences-q2-2026-financial-results BiopharmaWatch en 2026-07-31T11:01:00.000Z Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026 https://www.biopharmawatch.com/news/TLSA/tiziana-reports-reduction-brain-inflammation-msatreatment BiopharmaWatch en 2026-07-31T11:00:00.000Z Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab https://www.biopharmawatch.com/news/INMB/inmune-bio-receives-rd-rebates-4-6-million BiopharmaWatch en 2026-07-31T11:00:00.000Z INmune Bio Receives R&D Rebates of Approximately $4.6 Million https://www.biopharmawatch.com/news/RADX/radiopharm-theranostics-business-update BiopharmaWatch en 2026-07-31T11:00:00.000Z Radiopharm Theranostics Reports Business Update https://www.biopharmawatch.com/news/BTSG/brightspring-health-q2-2026-financial-results BiopharmaWatch en 2026-07-31T10:00:00.000Z BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance https://www.biopharmawatch.com/news/AMGN/amgen-scholars-program-india-launch-iiit-hyderabad BiopharmaWatch en 2026-07-31T00:00:00.000Z FIRST AMGEN SCHOLARS PROGRAM IN INDIA LAUNCHES AT IIIT HYDERABAD Amgen (NASDAQ: AMGN) today announced the launch of the first Amgen Scholars Program in India at the International Institute of Information Technology ... https://www.biopharmawatch.com/news/AMGN/repatha-chmp-positive-opinion-amgen BiopharmaWatch en 2026-07-31T00:00:00.000Z KLADNÉ STANOVISKO CHMP PODPORUJE ŠIRŠÍ POUŽITÍ PŘÍPRAVKU REPATHA® SPOLEČNOSTI AMGEN PŘED PRVNÍM INFARKTEM NEBO MOZKOVOU MRTVICÍ Společnost Amgen (NASDAQ: AMGN) dnes oznámila, že Výbor pro léčivé přípravky pro humánní použití (CHMP) Evropské agentury pro léčivé přípravky (EMA)... https://www.biopharmawatch.com/news/AMGN/chmp-positive-opinion-repatha-amgn BiopharmaWatch en 2026-07-31T00:00:00.000Z ПОЛОЖИТЕЛЬНАЯ ОЦЕНКА CHMP ПОДДЕРЖИВАЕТ БОЛЕЕ ШИРОКОЕ ПРИМЕНЕНИЕ ПРЕПАРАТА REPATHA® КОМПАНИИ AMGEN ДЛЯ СНИЖЕНИЯ РИСКА ПЕРВОГО ИНФАРКТА ИЛИ ИНСУЛЬТА Компания Amgen (NASDAQ: AMGN) сегодня объявила, что Комитет по лекарственным препаратам для медицинского применения (CHMP) Европейского агентства...